Literature DB >> 8025394

Clostridium perfringens in stool, intrapartum antibiotics and gastrointestinal signs in a neonatal intensive care unit.

P Ahtonen1, O P Lehtonen, P Kero, E Eerola, K Hartiala.   

Abstract

In 1989, we observed in our neonatal intensive care unit (NICU), an increased number of infants with gastrointestinal signs, including five cases of necrotizing enterocolitis. Clostridium perfringens was found in 26% of newborns (n = 168) and was associated significantly with the occurrence of flatulence, distended abdomen, foul-smelling stools, diarrhea and blood in stool (all p < 0.001). C. difficile was found in 17% of the newborns (n = 72). Cesarean section, low gestational age and low birth weight were significantly associated with C. perfringens in stools (all p < 0.001). Treatment with antibiotics was not associated with occurrence of C. perfringens. However, in infants with C. perfringens, intrapartum antibiotics were associated with increased appearance of abdominal distension (p < 0.05). Thus the antibiotics, which disturb primary colonization, may also favor the pathogenic role of opportunistic gut bacteria, such as C. perfringens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025394     DOI: 10.1111/j.1651-2227.1994.tb18125.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

1.  Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life.

Authors:  B Laubereau; B Filipiak-Pittroff; A von Berg; A Grübl; D Reinhardt; H E Wichmann; S Koletzko
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

2.  Molecular monitoring of succession of bacterial communities in human neonates.

Authors:  Christine F Favier; Elaine E Vaughan; Willem M De Vos; Antoon D L Akkermans
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

3.  Necrotizing enterocolitis of the neonate with Clostridium perfringens: diagnosis, clinical course, and role of alpha toxin.

Authors:  Elke Dittmar; Peter Beyer; Doris Fischer; Volker Schäfer; Heike Schoepe; Karl Bauer; Rolf Schlösser
Journal:  Eur J Pediatr       Date:  2007-10-20       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.